Molecular Design
Controlling the behavior of compounds and materials by manipulation of molecular properties.
Showing posts with label
SARS-CoV-2
.
Show all posts
Showing posts with label
SARS-CoV-2
.
Show all posts
Saturday, 28 January 2023
More approaches to design of covalent inhibitors of SARS-CoV-2 main protease
›
<< previous | I’ll pick up from the previous post on design covalent inhibitors of SARS-CoV-2 main protease (structure and chart num...
Thursday, 19 January 2023
Some approaches to design of covalent inhibitors of SARS-CoV-2 main protease
›
<< previous | next >> I last posted on Covid-19 early in 2021 and quite a lot has happened since then. Specifically, a number...
Tuesday, 12 January 2021
Tom Lehrer's guide to design of SARS-CoV-3 main protease inhibitors for treatment of COVID-32
›
<< previous || next >> It’s been ages since my last COVID-19 post (How not to repurpose a 'drug') and I’ll kick blog...
1 comment:
Saturday, 18 July 2020
SARS-CoV-2 main protease. Crowdsourcing, peptidomimetics and fragments
›
<< previous || next >> “Just take the ball and throw it where you want to. Throw strikes. Home plate don’t move.” Satchel P...
2 comments:
Wednesday, 27 May 2020
COVID-19 stuff
›
|| next >> It’s been ages since the last blog post. I’d been thinking of marking my return with an April Fools post but this didn’t ...
›
Home
View web version
